ICH-Q7 GMP Manufactured Active Drug Substance
TROMETHAMINE (TRIS)
*Low Bioburden, Low Endotoxin
ANALYSIS | SPECIFICATIONS |
---|---|
Appearance and Color | White / Crystals |
Appearance of Solution | Clear and Colorless |
Assay, Dried Substance | 99.0-100.5% |
Bacterial Endotoxins | ≤ 3.0 EU/g |
Chlorides | ≤100ppm |
Identification A, pH | 10.0-11.5 |
Identification B, Melting Point | 168-174 ºC |
Identification C, IR | Conforms to Reference Standard |
Identification D | Conforms to Reference Standard |
Iron | ≤10ppm |
Loss on Drying | ≤0.5% |
pH 5% | 10.0 – 11.5 |
Related Substances | ≤1.0% |
Sulfated Ash | ≤0.1% |
LBLE API Grade Tromethamine TRIS-2257 is suitable for use as a non-Sterile Active Pharmaceutical Ingredient manufactured in accordance with the ICH-Q7 Good Manufacturing Practice Guide.
The recommended retest period for Tromethamine is two years from the date of manufacture.
10kg, 25kg and 50kg pails.
American Manufactured - FDA Registered GMP Facilities: Parenteral Excipients, GMP Small Molecule Intermediates, GMP Biological Buffers, Parenteral Carbohydrates, GMP Chlorinated Amino Acids, GMP Solutions in Sterile Single Use Packaging and other Reagent & GMP Fine Chemicals.